We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

News   Jan 11, 2018 | Original story from National Institutes of Health

 
Safety and Efficacy of MERS Treatment Confirmed in Phase I Trial

The round, spiked objects at center are MERS coronavirus particles. Credit: NIAID

 
 
 

RELATED ARTICLES

Scientists Discover Intricacies of Serotonin Receptor Crucial for Better Drugs

News

Researchers have figured out precisely why one drug binds to the serotonin receptor 5-HT2BR and activates it to cause heart problems while very similar drugs do not. They've also discovered why a third drug acts like a 5-HT2BR antagonist - it blocks the receptor's activity - while the very well-known similar hallucinogenic drug LSD does not.

READ MORE

Mouse Model Shows Gene Therapy Vectors Carrying Telomerase Gene Do Not Increase Cancer Risk

News

Gene therapy with telomerase was developed in 2012 and has proved effective in mice against infarction, as well as in mouse models of aplastic anaemia and idiopathic pulmonary fibrosis associated to short telomeres.

READ MORE

Antibiotic Candidates Discovered

News

MIT researchers have discovered that peptides normally secreted by cells that line the stomach have previously unknown antimicrobial activity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE